Synergy Asset Management’s Gilead Sciences GILD Stock Holding History

Synergy Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,661	Closed	-$204K	–	274
2025 Q4	$204K	Sell	1,661 -8,187	-83%	-$995K	0.02%	219
2025 Q3	$1.21M	Buy	9,848 +4,924	+100%	+$560K	0.04%	163
2025 Q2	$546K	Sell	4,924 -101,576	-95%	-$10.8M	0.06%	119
2025 Q1	$11.9M	Sell	106,500 -85,305	-44%	-$8.8M	1.5%	19
2024 Q4	$17.3M	Buy	191,805 +152,788	+392%	+$13.8M	1.34%	17
2024 Q3	$3.27M	Buy	39,017 +20,491	+111%	+$1.56M	0.5%	48
2024 Q2	$1.27M	Sell	18,526 -32,313	-64%	-$2.16M	0.2%	73
2024 Q1	$3.72M	Buy	+50,839	New	+$3.91M	0.63%	42
2023 Q4	–	Sell	-45,381	Closed	-$3.4M	–	153
2023 Q3	$3.4M	Buy	+45,381	New	+$3.49M	0.67%	44

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Synergy Asset Management's GILD Position: Q1 2026 in Review

Synergy Asset Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 1,661 shares — an estimated $204K sold.

Synergy Asset Management first reported a position in GILD in Q3 2023 and held it in 9 quarters. The position peaked at $17.3M in Q4 2024. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Synergy Asset Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Synergy Asset Management sold 1,661 Gilead Sciences shares in Q1 2026, an estimated $204K.
Synergy Asset Management first reported a position in Gilead Sciences in Q3 2023 and held it in 9 quarters.
Synergy Asset Management's Gilead Sciences position peaked at $17.3M in Q4 2024.
2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Synergy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.